KT
Pasithea Therapeutics Corp. Warrants (KTTAW)
NASDAQ·Healthcare·Biotechnology
$0.00
—
Mkt Cap $75.91K
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$243.80
Range $165.36 – $286.20
Implied Upside
+8707042.9%
Consensus $243.80 vs current $0.00